Results for the substance didanosine:

DIDANOZINA AUROBINDO 250mg gastro-resistant capsules

Chemical substance: didanosine

ATC code: J05AF02 • Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

Prescription: P-RF
DIDANOZINA AUROBINDO 400mg gastro-resistant capsules

Chemical substance: didanosine

ATC code: J05AF02 • Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

Prescription: P-RF
VIDEX EC 250mg gastro-resistant capsules BRISTOL MYERS SQUIBB ORIGINAL
MEDICINE

Chemical substance: didanosine

ATC code: J05AF02 • Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

Prescription: P-RF
VIDEX EC 400mg gastro-resistant capsules BRISTOL MYERS SQUIBB ORIGINAL
MEDICINE

Chemical substance: didanosine

ATC code: J05AF02 • Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

Prescription: P-RF
VIDEX EC 200mg gastro-resistant capsules BRISTOL MYERS SQUIBB ORIGINAL
MEDICINE

Chemical substance: didanosine

ATC code: J05AF02 • Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

Prescription: P-RF
VIDEX EC 125mg gastro-resistant capsules BRISTOL MYERS SQUIBB ORIGINAL
MEDICINE

Chemical substance: didanosine

ATC code: J05AF02 • Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

Prescription: P-RF
VIDEX 100mg dispersible / chewable tablets BRISTOL MYERS SQUIBB ORIGINAL
MEDICINE

Chemical substance: didanosine

ATC code: J05AF02 • Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

Prescription: P-RF
VIDEX 150mg dispersible / chewable tablets BRISTOL MYERS SQUIBB ORIGINAL
MEDICINE

Chemical substance: didanosine

ATC code: J05AF02 • Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

Prescription: P-RF